HomeDilutionPromotionUplist RadarBuzzToday on EDGARDead Stock Check
PubCo Insight › Tickers › EDIT

$EDITNASDAQ NMS - GLOBAL MARKET

Editas Medicine, Inc.
Biotechnology
Market Cap
$453.1M
Exchange
NASDAQ NMS - GLOBAL MARKET
Filings (365d)
43
News (14d)
3
CIK
0001650664
Website
Company site ↗
SEC Filing Timeline
8-KOct 08, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
S-3Aug 31, 2026
Shelf registration
10-QAug 05, 2026
Quarterly report
8-KAug 05, 2026
Executive officer change · Items 2.02,5.02,9.01
8-KJun 18, 2026
Shareholder vote results · Items 5.07
424B5May 26, 2026
Prospectus / offering
8-KMay 26, 2026
Material agreement · Items 1.01,8.01,9.01
8-KMay 26, 2026
Other material event · Items 8.01
424B5May 26, 2026
Prospectus / offering
8-KMay 26, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KMay 14, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
10-QMay 05, 2026
Quarterly report
8-KMay 05, 2026
Earnings release · Items 2.02,9.01
Recent News (Finnhub)
What Would Slower New Drug Sales Do To Vertex Stock?
Yahoo · Oct 28
Vertex Stock Looks Expensive. Does It Get Cheaper Ahead?
Yahoo · Oct 23
Why Should You Think About Vertex Differently Now?
Yahoo · Oct 21
Source-linked from SEC EDGAR + Finnhub aggregated news.
Not investment advice. Always verify on SEC.gov directly.
Investor relations · EDIT
Is this how AI describes Editas Medicine, Inc.?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for EDIT: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent EDIT, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
PubCo Insight

See the dilution and promotion flags before you see the pitch.

Each week: the micro and small-caps now showing dilution or paid-promotion signals, with the SEC filing behind every flag. No recommendations, no price targets.

Every flag links to its EDGAR filing so you can check it yourself. Sponsored coverage disclosed under SEC 17(b). One-click unsubscribe.